Inna Perevozskaya

发表

Adaptive Approaches in Clinical Drug Development

Amarnath Sharma, Michael Krams, Vlad Dragalin, 2012, Pharmaceutical Medicine.

Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies

Amarnath Sharma, Kathy Reinold, Michael Krams, 2009 .

A Simulation Study to Compare New Adaptive Dose–Ranging Designs

Frank Bretz, Joshua R. Smith, José Pinheiro, 2010 .

Constrained Bayesian Optimal Designs for Phase I Clinical Trials: Continuous Dose Space

William F. Rosenberger, Linda M. Haines, Inna Perevozskaya, 2001 .

Adaptive Dose-Response Studies

Paul Gallo, Brenda Gaydos, Michael Krams, 2006 .

Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via Simulations

Olga Marchenko, Joel Miller, Inna Perevozskaya, 2013, Therapeutic innovation & regulatory science.

Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?

Christopher Jennison, Guochen Song, Anastasia Ivanova, 2017, Journal of biopharmaceutical statistics.

Continual Reassessment Method for a First-in-Human Trial: From Design to Trial Implementation

Lixin Han, Inna Perevozskaya, Kristen J. Pierce, 2014 .

Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 1. The Process

Amarnath Sharma, Kathy Reinold, Michael Krams, 2009 .

Development of Interactive Software for Bayesian Optimal Phase 1 Clinical Trial Design*

William F. Rosenberger, Linda M. Haines, Inna Perevozskaya, 2005 .

Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Studies

Frank Bretz, Joshua R. Smith, Chyi-Hung Hsu, 2010 .

Adaptive dose finding based on t‐statistic for dose–response trials

Anastasia Ivanova, Inna Perevozskaya, A. Ivanova, 2008, Statistics in medicine.

Optimal design for the proportional odds model

William F. Rosenberger, Linda M. Haines, Inna Perevozskaya, 2003 .